dimephosphon has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maksudova, AN; Sigitova, ON | 1 |
| Dudar, IO; Kolesnyk, MO; Pyrih, LA | 1 |
2 other study(ies) available for dimephosphon and Bright Disease
| Article | Year |
|---|---|
[Informative value of immunomembrane indicator of glomerulonephritis activity and effectiveness of membranostabiliser dimephosphon].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Antibody Complex; Antineoplastic Agents; Biomarkers; Biopsy; Disease Progression; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis; Glucocorticoids; Humans; Lipid Peroxidation; Male; Middle Aged; Organophosphorus Compounds; Phospholipids; Severity of Illness Index; Treatment Outcome | 1999 |
[The efficacy of treating glomerulonephritis patients with a hematuria component].
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Drug Evaluation; Drug Therapy, Combination; Glomerulonephritis; Hematuria; Humans; Organophosphorus Compounds; Remission Induction; Unithiol; Vitamin E | 1992 |